Interest of cystatin C in the evaluation of renal function;L'intérêt de la cystatine C dans l'évaluation de la fonction rénale

Nephrologie

Volumn 24, Issue 8, 2003, Pages 457-468

  Delanaye, Pierre ^a   Chapelle, J P ^a   Gielen, J ^a   Krzesinski, J M ^a   Rorive, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cockcroft; Creatinine clearance; Cystatin C; Seric creatinine

Indexed keywords

CREATININE; STEFIN A;

BODY MASS; CATABOLISM; CLINICAL PRACTICE; CREATININE CLEARANCE; DIAGNOSTIC VALUE; GLOMERULUS; GLOMERULUS FILTRATION RATE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; REVIEW; URINALYSIS;

BIOLOGICAL MARKERS; CYSTATINS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES;

EID: 0348142169     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens 1999; 17: 309-17.
2. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39 (2 Suppl. 2): S1-246.
3. Cameron J, Greger R. Renal function and testing of function. In: Oxford university press, editor. Oxford textbook of clinical nephrology. Oxford, 1998; 39-69.
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
5. Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, et al. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis 1998; 32: 32-42.
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
7. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 2001; 38: 744-53.
8. Lubowitz H, Slatopolsky E, Shankel S, Rieselbach RE, Bricker NS. Glomerular filtration rate. Determination in patients with chronic renal disease. JAMA 1967; 199: 252-6.
9. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38: 1933-53.
10. Schwartz GJ, Haycock GB, Edelmann CM, Jr., Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-63.
11. Swan SK. The search continues-an ideal marker of GFR. Clin Chem 1997; 43 (6 Pt 1): 913-4.
12. Smith HW. The kidney: Structure and function in health and disease. New York: Oxford University Press, 1951.
13. Chantler C, Garnett ES, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 1969; 37: 169-80.
14. Brandstrom E, Grzegorczyk A, Jacobsson L, Friberg P, Lindahl A, Aurell M. GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-82.
15. Gronberg T, Sjoberg S, Almen T, Golman K, Mattsson S. Noninvasive estimation of kidney function by x-ray fluorescence analysis. Elimination rate and clearance of contrast media injected for urography in man. Invest Radiol 1983; 18: 445-52.
16. Guesry P, Kaufman L, Orloff S, Nelson JA, Swann S, Holliday M. Measurement of glomerular filtration rate by fluorescent excitation of non-radioactive meglumine iothalamate. Clin Nephrol 1975; 3: 134-8.
17. Krutzen E, Back SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: A method for the assessment of glomerular filtration rate. J Lab Clin Med 1984; 104: 955-61.
18. Turk V, Brzin J, Longer M, Ritonja A, Eropkin M, Borchart U, et al. Protein inhibitors of cysteine proteinases. III. Amino-acid sequence of cystatin from chicken egg white. Hoppe Seylers Z Physiol Chem 1983; 364: 1487-96.
19. Reed CH. Diagnostic applications of cystatin C. Br J Biomed Sci 2000; 57: 323-9.
20. Hall A, Hakansson K, Mason RW, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 1995; 270: 5115-21.
21. Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984; 120: 631-6.
22. Clausen J. Protein in normal cerebrospinal fluid not found in serum. Proc Soc Exp Biol Med 1961; 107: 170-2.
23. Lofberg H, Grubb AO. Quantitation of gamma-trace in human biological fluids: Indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39: 619-26.
24. Schnittger S, Rao VV, Abrahamson M, Hansmann I. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2. Genomics 1993; 16: 50-5.
25. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 (Suppl. 1): S20-S7.
26. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287-94.
27. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Twenty-four hour variations of cystatin C and total cysteine proteinase inhibitory activity in sera from healthy subjects. Clin Chim Acta 2000; 291: 89-95.
28. Randers E, Kornerup K, Erlandsen EJ, Hasling C, Danielsen H. Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels. Scand J Clin Lab Invest 2001; 61: 333-5.
29. Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995; 26: 559-64.
30. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56: 409-14.
31. Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002; 323: 121-8.
32. Mussap M, Ruzzante N, Varagnolo M, Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med 1998; 36: 859-65.
33. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43 (6 Pt 1): 1016-22.
34. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999; 59: 1-8.
35. Abrahamson M, Buttle DJ, Mason RW, Hansson H, Grubb A, Lilja H, et al. Regulation of cystatin C activity by serine proteinases. Biomed Biochim Acta 1991; 50: 587-93.
36. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985; 45: 97-101.
37. Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985; 218: 499-503.
38. Olafsson I, Lofberg H, Abrahamson M, Grubb A. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand J Clin Lab Invest 1988; 48: 573-82.
39. Joronen I, Hopsu-Havu VK, Manninen M, Rinne A, Jarvinen M, Halonen P. Detection of low molecular weight cysteine proteinase inhibitors by time-resolved fluoroimmunoassay. J Immunol Methods 1986; 86: 243-7.
40. Poulik MD, Perry DJ, Vokac E, Sekine T. Post-gamma globulin II. Radioimmunoassay determination of levels of post-gamma globulin and beta 2-microglobulin. Clin Chim Acta 1983; 128: 249-60.
41. Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 1989; 8: 303-13.
42. Colle A, Tavera C, Prevot D, Leung-Tack J, Thomas Y, Manuel Y, et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J Immunoassay 1992; 13: 47-60.
43. Pergande M, Jung K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin Chem 1993; 39: 1885-90.
44. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-6.
45. Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: lohexol clearance and cystatin C serum concentration. Kidney Int Suppl 1994; 47: S17-S9.
46. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-8.
47. Lewis AV, James TJ, McGuire JB, Taylor RP. Improved immunoturbidimetric assay for cystatin C. Ann Clin Biochem 2001; 38 (Pt 2): 111-4.
48. Stowe H, Lawrence D, Newman DJ, Lamb EJ. Analytical performance of a particle-enhanced nephelometric immunoassay for serum cystatin C using rate analysis. Clin Chem 2001; 47: 1482-5.
49. Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med 2001; 39: 850-7.
50. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 1535-9.
51. Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999; 14: 1991-6.
52. Lewis AV, James TJ, Tan G, Levy JC, Taylor RP. Plasma cystatin C has lower biovariability and greater correlation with creatinine clearance than creatinine in mild to moderate diabetic nephropathy. The association of clinical biochemists.(Abstract) 2000; 76-7.
53. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 1999; 59: 587-92.
54. Rodrigo E, De Francisco AL, Escallada R, Ruiz JC, Fresnedo GF, Pinera C, et al. Measurement of renal function in pre-ESRD patients. Kidney Int 2002; 61 (Suppl. 80): 11-7.
55. Tan GD, Lewis AV, James TJ, Altmann P, Taylor RP, Levy JC. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 2002; 25: 2004-9.
56. Hayashi T, Nitta K, Hatano M, Nakauchi M, Nihei H. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis. Nephron 1999; 82: 90-2.
57. Harmoinen AP, Kouri TT, Wirta OR, Lehtimaki TJ, Rantalaiho V, Turjanmaa VM, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1999; 52: 363-70.
58. Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol 2000; 54: 203-9.
59. Mussap M, Dalla VM, Fioretto P, Saller A, Varagnolo M, Nosadini R, et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-61.
60. Plebani M, Dall'Amico R, Mussap M, Montini G, Ruzzante N, Marsilio R, et al. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Ren Fail 1998; 20: 303-9.
61. Le Bricon T, Thervet E, Froissart M, Benlakehal M, Bousquet B, Legendre C, et al. Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem 2000; 46 (8 Pt 1): 1206-7.
62. Paskalev E, Lambreva L, Simeonov P, Koicheva N, Beleva B, Genova M, et al. Serum cystatin C in renal transplant patients. Clin Chim Acta 2001; 310: 53-6.
63. Li FK, Ho SK, Yip TP, Tse KC, Chan TM, Lai KN. Cystatin C assay for the detection of renal dysfunction in Chinese renal transplant recipients. Clin Chim Acta 2002; 322: 133-7.
64. Leach TD, Kitiyakara C, Price CP, Stevens JM, Newman DJ. Prognostic significance of serum cystatin C concentrations in renal transplant recipients: 5-year follow-up. Transplant Proc 2002; 34: 1152-8.
65. Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 1999; 45: 2243-9.
66. Herget-Rosenthal S, Trabold S, Huesing J, Heemann U, Philipp T, Kribben A. Cystatin C-an accurate marker of glomerular filtration rate after renal transplantation? Transpl Int 2000; 13: 285-9.
67. Finney H, Bates C, Price CP. Plasma cystatin C determination in a healthy elderly population. Arch Gerontol Geriatr 1999; 29: 75-94.
68. Bokenkamp A, Ozden N, Dieterich C, Schumann G, Ehrich JH, Brodehl J. Cystatin C and creatinine after successful kidney transplantation in children. Clin Nephrol 1999; 52: 371-6.
69. Thervet E, Le Bricon T, Hugot V, Benlakehal M, Bedrossian J, Beuzard Y, et al. Early diagnosis of renal function recovery by cystatin C in renal allograft recipients. Transplant Proc 2000; 32: 2779.
70. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem 1999; 45: 1866-8.
71. Hermida J, Romero R, Tutor JC. Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients. Kidney Int 2001; 60: 1561-4.
72. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154: 201-5.
73. Orlando R, Floreani M, Padrini R, Palatini P. Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin Nephrol 1999; 51: 341-7.
74. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48 (6 Pt 1): 850-8.
75. Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 1987; 82: 945-52.
76. Woitas RP, Stoffel-Wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr HU, et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000; 46: 712-5.
77. Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50: 106-10.
78. Randers E, Ivarsen P, Erlandsen EJ, Hansen EF, Aagaard NK, Bendtsen F, et al. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis. Scand J Clin Lab Invest 2002; 62: 129-34.
79. Kabanda A, Goffin E, Bernard A, Lauwerys R, van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 1995; 48: 1946-52.
80. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, van Ypersele de Strihou C, Bernard A. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int 1994; 45: 1689-96.
81. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58: 585-92.
82. Tian S, Kusano E, Ohara T, Tabei K, Itoh Y, Kawai T, et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48: 104-8.
83. Filler G, Witt I, Priem F, Ehrich JH, Jung K. Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 1997; 43 (6 Pt 1): 1077-8.
84. Randers E, Krue S, Erlandsen EJ, Danielsen H, Hansen LG. Reference interval for serum cystatin C in children. Clin Chem 1999; 45: 1856-8.
85. Fischbach M, Graff V, Terzic J, Bergere V, Oudet M, Hamel G. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol 2002; 17: 104-6.
86. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000; 82: 71-5.
87. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 1998; 12: 125-9.
88. Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: Relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999; 16: 287-95.
89. Solberg HE. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987; 25: 337-42.
90. Norlund L, Fex G, Lanke J, Von Schenck H, Nilsson JE, Leksell H, et al. Reference intervals for the glomerular filtration rate and cell- proliferation markers: Serum cystatin C and serum beta 2- microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 1997; 57: 463-70.
91. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37 (Pt 1): 49-59.
92. Erlandsen EJ, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med 1998; 36: 393-7.
93. Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenck H, et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998; 36: 175-8.
94. Wasen E, Suominen P, Isoaho R, Mattila K, Virtanen A, Kivela SL, et al. Serum cystatin C as a marker of kidney dysfunction in an elderly population. Clin Chem 2002; 48: 1138-40.
95. Back SE, Ljungberg B, Nilsson-Ehle I, Borga O, Nilsson-Ehle P. Age dependence of renal function: Clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest 1989; 49: 641-6.
96. Krieser D, Rosenberg AR, Kainer G, Naidoo D. The relationship between serum creatinine, serum cystatin C and glomerular filtration rate in pediatric renal transplant recipients: A pilot study. Pediatr Transplant 2002; 6: 392-5.
97. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617-23.
98. Filler G, Pham-Huy A. Cystatin C should be measured in pediatric renal transplant patients! Pediatr Transplant 2002; 6: 357-60.
99. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47: 2055-9.
100. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000; 300: 83-95.
101. Bokenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B. Effect of corticosteroid therapy on serum cystatin C and beta2- microglobulin concentrations. Clin Chem 2002; 48: 1123-6.
102. Risch L, Huber AR. Glucocorticoids and increased serum cystatin C concentrations. Clin Chim Acta 2002; 320: 133-4.
103. Sloane BF. Suicidal tumor proteases. Nat Biotechnol 1996; 14: 826-7.
104. Kos J, Stabuc B, Cimerman N, Brunner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 1998; 44: 2556-7.
105. Page MK, Bukki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta 2000; 297: 67-72.
106. Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem 2000; 46: 193-7.
107. Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chim Acta 2001; 309: 1-6.
108. Mojiminiyi OA, Marouf R, Abdella N, Kortom M, Abdul-Razzak R. Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders. Ann Clin Biochem 2002; 39 (Pt 3): 308-10.
109. Newman DJ. Cystatin C. Ann Clin Biochem 2002; 39 (Pt 2): 89-104.
110. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002; 40: 221-6.
111. Dubois B, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71.
112. van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340: 1326-9.
113. Berlyne G. Endogenous creatinine clearance and glomerular filtration rate. Lancet 1964; 2: 874-6.
114. Hottelart C, el Esper N, Achard JM, Pruna A, Fournier A. Le fénofibrate augmente la créatinémie mais n'altère pas le débit de filtration glomérulaire chez les patients présentant une insuffisance rénale modérée. Nephrologie 1999; 20: 41-4.
115. Mayersohn M, Conrad KA, Achari R. The influence of a cooked meat meal on creatinine plasma concentration and creatinine clearance. Br J Clin Pharmacol 1983; 15: 227-30.
116. Mitch WE, Collier VU, Walser M. Creatinine metabolism in chronic renal failure. Clin Sci (Lond) 1980; 58: 327-35.
117. Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998; 32: 23-31.
118. Seco ML, Rus A, Sierra M, Caballero M, Borque L. Determination of serum cystatin C in patients with essential hypertension. Nephron 1999; 81: 446-7.
119. Herget-Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000; 20: 97-102.
120. Meier P, Froidevaux C, Dayer E, Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet 2001; 357: 634-5.
121. Mangge H, Liebmann P, Tanil H, Herrmann J, Wagner C, Gallistl S, et al. Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. Clin Chim Acta 2000; 300: 195-202.
122. Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 81-9.
123. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83.
124. O'Riordan S, Ouldred E, Brice S, Jackson SH, Swift CG. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol 2002; 53: 398-402.
125. Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002; 62: 141-7.
126. Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002; 91: 13-20.
127. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34.
128. Chantrel F, Agin A, Offner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol 2000; 54: 374-81.
129. Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: Comparison with plasma creatinine. J Pharm Biomed Anal 2001; 24: 835-42.
130. Oddoze C, Morange S, Portugal H, Berland Y, Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001; 38: 310-6.
131. Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 2002; 50: 1278-82.
132. Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, et al. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl 2002; 8: 594-9.
133. Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 2000; 15: 105-8.
134. Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol 1998; 49: 221-5.
135. Stickle D, Cole B, Hock K, Hruska KA, Scott MG. Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 1998; 44 (6 Pt 1): 1334-8.
136. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101: 875-81.
137. Ylinen EA, Ala-Houhala M, Harmoinen AP, Knip M. Cystatin C as a marker for glomerular filtration rate in pediatric patients. Pediatr Nephrol 1999; 13: 506-9.
138. Filler G, Priem F, Vollmer I, Gellermann J, Jung K. Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr Nephrol 1999; 13: 501-5.
139. Kilpatrick ES, Keevil BG, Addison GM. Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C? Arch Dis Child 2000; 82: 499-502.
140. Filler G, Priem F, Lepage N, Sinha P, Vollmer I, Clark H, et al. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 2002; 48: 729-36.